Behcet's disease: from east to west

被引:206
|
作者
Davatchi, Fereydoun [1 ]
Shahram, Farhad [1 ]
Chams-Davatchi, Cheyda [1 ]
Shams, Hormoz [1 ]
Nadji, Abdolhadi [1 ]
Akhlaghi, Massoomeh [1 ]
Faezi, Tahereh [1 ]
Ghodsi, Zahra [1 ]
Faridar, Alireza [1 ]
Ashofteh, Farima [1 ]
Abdollahi, Bahar Sadeghi [1 ]
机构
[1] Univ Tehran Med Sci, Shariati Hosp, Rheumatol Res Ctr, Behcets Dis Unit, Tehran 14114, Iran
关键词
Behcet's disease; ASSOCIATION; POPULATION; INVOLVEMENT; GENE;
D O I
10.1007/s10067-010-1430-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease (BD) is classified among vasculitides. There are actually five nationwide surveys of BD: Iran, Japan, China, Korea, and Germany. Among case series, four are on more than 200 cases (Turkey, Morocco, Tunisia, and UK). BD was classically seen around the Silk Route. Now, it is seen everywhere. The male to female ratios were, respectively (in nationwide surveys), 1.19, 0.98, 1.34, 0.63, and 1.40 to 1. The mean age at onset was 26.2, 35.7, 33.8, 29, and 26 years. Major manifestations were seen, respectively, in nationwide surveys: mucous membrane (oral aphthosis in 97%, 98%, 98%, 99%, and 98%; genital aphthosis in 65%, 73%, 76%, 83%, and 64%); skin manifestations (pseudo-folliculitis in 57%, N/A, 31%, N/A, and 62%; erythema nodosum in 22%, N/A, 38%, N/A, and 42%; ocular manifestations in 55%, 69%, 35%, 51%, and 53%). Minor manifestations were seen, respectively, in nationwide surveys: joint manifestations in 33%, 57%, 30%, 38%, and 53%; neurological manifestations in 9%, 11%, 6.5%, 4.6%, and 11%; gastrointestinal manifestations in 7%, 15.5%, 9%, 7.3%, and 12%; vascular involvement in 8.9%, 8.9%, 7.7%, 1.8%, and 13%; pulmonary manifestations in 0.3%, N/A, 2.2%, N/A, and 3.6%; cardiac manifestations in 0.5%, N/A, 4%, N/A, and 3.2%. Laboratory tests are not useful except the pathergy test, which was positive in 54%, 44%, N/A, 40%, and 34% of cases. ESR was normal in many patients. Diagnosis is based upon clinical manifestations. The International Criteria for Behcet's Disease (ICBD, 2006) may be of help, having a sensitivity of 98.2% and a specificity of 95.6% in Iranian patients.
引用
收藏
页码:823 / 833
页数:11
相关论文
共 50 条
  • [41] eComment. Behcet's disease or Adamantiades-Behcet's disease?
    Dimitrakakis, Georgios
    Dimitrakaki, Inetzi A.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 14 (03) : 373 - 374
  • [42] Viral retinopathies: a spectrum of disease from East to West
    Bodaghi, B.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [43] How to diagnose Behcet's and intestinal Behcet's disease?
    Celik, A. F.
    Pamuk, Oe. N.
    Melikoglu, M.
    Yazici, H.
    IBD 2007 - ACHIEVEMENTS IN RESEARCH AND CLINICAL PRACTICE, 2008, 159 : 118 - 128
  • [44] Fatal hemoptysis from Behcet's disease in a child
    Cohle, SD
    Colby, T
    CARDIOVASCULAR PATHOLOGY, 2002, 11 (05) : 296 - 299
  • [45] Behcet's disease: from Hippocrates to the third millennium
    Verity, DH
    Wallace, GR
    Vaughan, RW
    Stanford, MR
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (09) : 1175 - 1183
  • [46] Behcet's disease: from innate to adaptive immunity
    Direskeneli, H
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 2) : S4 - S4
  • [47] Epidemiology of Parkinson's Disease-East Versus West
    Abbas, Masoom M.
    Xu, Zheyu
    Tan, Louis C. S.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (01): : 14 - 28
  • [48] FAMILIAL BEHCET'S DISEASE: A REPORT OF 2 CASES FROM AN ITALIAN BEHCET FAMILY
    Carriero, A.
    Corrado, A.
    Di Bello, S.
    Tiso, A.
    D'Onofrio, F.
    Cantatore, F. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : S181 - S181
  • [49] Adamantiades-Behcet's disease (Behcet's disease) and COVID-19
    Zouboulis, C. C.
    van Laar, J. A. M.
    Schirmer, M.
    Emmi, G.
    Fortune, F.
    Gul, A.
    Kirino, Y.
    Lee, E. -S.
    Sfikakis, P. P.
    Shahram, F.
    Wallace, G. R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (09) : E541 - E543
  • [50] Behcet's disease as a systemic disease
    Mat, M. Cem
    Sevim, Aysegul
    Fresko, Izzet
    Tuzun, Yalcin
    CLINICS IN DERMATOLOGY, 2014, 32 (03) : 435 - 442